• Jobs
    • RANZCR Jobs
  • Apply
  • Careers
  • Events
    • Global
    • Local
  • News
  • Contact
  • Jobs
    • RANZCR Jobs
  • Apply
  • Careers
  • Events
    • Global
    • Local
  • News
  • Contact
30
May

iSono Health receives US FDA approval for breast imaging ultrasound system

Breast Cancer, Breast cancer imaging, breast cancer machine, Breast cancer screening, Breast imaging ultrasound system, CT, Healthcare Excellence, iSono Health, magnetic resonance imaging, MRI, Personalised breast imaging, Radiology, Wearable Imaging System

Source: Breast cancer is the leading cause of cancer death among women worldwide, one in eight women will be diagnosed with breast cancer in their lifetime. iSono Health has received approval from the US Food and Drug Administration (FDA) for its ultrasound wearable system, which has been designed for personalised breast imaging.

PrevNext

Related Posts

February 4, 2023

Bivalent Vaccine Slashes COVID Hospitalisations in Seniors

increaseoNews0
January 28, 2023

MRI-Targeted Biopsy for Prostate Cancer Reduces Risk of Overdiagnosis

increaseoNews0
January 24, 2023

Optimising Treatment for Older Patients With HR + Low-Risk Breast Cancer

increaseoNews0

Latest News

  • Perioperative Chemo Matches Multimodal Tx for Locally Advanced Esophageal/GEJ Cancer
  • Bivalent Vaccine Slashes COVID Hospitalisations in Seniors
  • AI Passes U.S. Medical Licensing Exam

About Us

GCG Global Healthcare are specialists in healthcare excellence. Driven by a desire to improve healthcare and clinical solutions for everyone – patients, medical professionals and facilities. We aim to foster a culture of excellence through collaboration with industry experts and thought leaders to deliver better outcomes.

RSS Health Pulse

  • Haven't had COVID or a vaccine dose in the past six months? Consider getting a booster
  • How can the health regulator better protect patients from sexual misconduct?
  • The TGA has approved certain psychedelic treatments: the response from experts is mixed

Twitter

  • A short course of perioperative chemotherapy for locally advanced esophageal/gastroesophageal junction (GEJ) cancer… https://t.co/f3G4yHaaaY yesterday
  • The bivalent COVID-19 booster targeting BA.4/5 showed high levels of protection against COVID-19 hospitalisation in… https://t.co/nvQ57p1gn9 4 days ago
  • Two artificial intelligence (AI) programs, including ChatGPT, have passed the U.S. Medical Licensing Examination (U… https://t.co/pggehVE7vP 6 days ago
© GCG Global Healthcare Pty Ltd, All rights reserved. ABN 25 136 716 991

Find your next opportunity with
GCG Global Healthcare TODAY!

DISCOVER OUR OPEN POSITIONS NOW!